A selective, irreversible inhibitor of Type B monoamine oxidase that is used for the treatment of newly diagnosed patients with PARKINSON DISEASE, and for the treatment of depressive disorders. The compound without isomeric designation is Deprenyl.
Pharmacology effect
antiparkinsoniká inhibítory monoaminooxidázy látky neuroprotektívne
